Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 28474669.
- Also identified by DOI 10.1038/ncomms15178 and PMC identifier 5424143.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
CRISPR-Cas9 screens are powerful tools for high-throughput interrogation of genome function, but can be confounded by nuclease-induced toxicity at both on- and off-target sites, likely due to DNA damage. Here, to test potential solutions to this issue, we design and analyse a CRISPR-Cas9 library with 10 variable-length guides per gene and thousands of negative controls targeting non-functional, non-genic regions (termed safe-targeting guides), in addition to non-targeting controls. We find this library has excellent performance in identifying genes affecting growth and sensitivity to the ricin toxin. The safe-targeting guides allow for proper control of toxicity from on-target DNA damage. Using this toxicity as a proxy to measure off-target cutting, we demonstrate with tens of thousands of guides both the nucleotide position-dependent sensitivity to single mismatches and the reduction of off-target cutting using truncated guides. Our results demonstrate a simple strategy for high-throughput evaluation of target specificity and nuclease toxicity in Cas9 screens.
Medical subject headings
- CRISPR-Cas Systems
- Gene Targeting
- Genomic Library
- High-Throughput Screening Assays
- RNA, Guide, CRISPR-Cas Systems